Cetoniacytone A (1) and some related minor components (2, 6, 7) were produced by Actinomyces sp. (strain Lu 9419), which was isolated from the intestines of a rose chafer (Cetonia aureata). The structures of the novel metabolites were established by detailed spectroscopic analysis. The absolute configuration of 1 was determined by X-ray analysis and derivatisation with chiral acids. 1 exhibits a significant cytotoxicity against selected tumor cell lines. The biosynthesis of 1 was studied by feeding 13C labelled precursors. The results suggest that the characteristic p-C7N skeleton of the aminocarba sugar is formed via the pentose phosphate pathway by cyclisation of a heptulose phosphate intermediate.
In the course of our screening program for new secondary metabolites2) we investigated endosymbionts, which were isolated from several members of Crustacea (wood-lice), Myriapoda (millipedes) and Hexapoda (insects)3). In the culture broth of Actinomyces sp. (strain Lu 9419), which was isolated from the intestines of a rose chafer (Cetonia aureata) we identified two novel aminocarba sugars, which were named cetoniacytone A (1) and B (2) . Carba sugars and aminocarba sugars are widespread metabolites produced especially by actinomycetes. Many of their natural derivatives are biologically active, well known examples are validamycin A4) and acarbose5), both containing valienamine (3) . Structurally related to the cetoniacytones are epoxyquinomicin C (4) and D (5), which were isolated from the culture broth of an Amycolatopsis sp6), They possess anti-arthritic effects on type II collagen-induced arthritis in mice7) and inhibited the histidine decarboxylase in rat embryos8).
Different biosynthetic pathways leading to carbocyclic Additionally we report the structures of three novel minor components, cetoniacytone B (2) and two aromatic analogues (6, 7).
Fermentation and Isolation
Actinomyces sp. (strain Lu 9419) was cultivated in shaking flasks, using oatmeal medium with sodium acetate described metabolites were only found in the culture filtrate, which was separated from the mycelium by centrifugation. The filtrate was passed through Amberlite(R) XAD-2, from which the metabolites were eluated with methanol. The evaporation residue was separated by successive column chromatography on silica gel and Sephadex LH-20 leading to 10-15mg/liter of cetoniacytone A (1). Besides 4.8mg/liter of 1a cultivation in absence of sodium acetate yielded 5.6mg/liter of cetoniacytone B (2). Addition of glucose (1g/liter) after 48 hours, when the production of 1 has just started, increased the yield of 1 to 20.25mg/liter. However, addition of glucose at the beginning of the fermentation had no influence on the yield of 1. A scale-up using a 50-liter stirring fermenter yielded 85mg of 1 and allowed the isolation of minor components: 34mg of 2, 5-dihydroxy-4-hydroxymethylacetanilide (6), 4.1mg of 2, 5-dihydroxy-4-methoxymethylacetanilide (7) and 9.4mg of 2-acetamido-phenol. All compounds are detectable on silica gel TLC-plates with UV light at 254nm and when treated with anisaldehyde-H2SO4 show clearly recognizable colour reactions after heating.
Structure Elucidation
The molecular formula of 1 was determined by HREI- The molecular formula of cetoniacytone B (2) was determined by HREI-MS to be C7H9NO4. 2 was revealed to be the N-deacetyl derivative of 1 by comparison of the 1H and 13C NMR spectral data.
The HREI-MS of 2,5-dihydroxy-4-hydroxymethylacetanilide (6) Biological Activities
In agar plate diffusion assays cetoniacytone A (1) showed no antimicrobial activity against Gram-positive and Gram-negative bacteria at concentrations up to 1mg/ml. 1 was also tested against three human cancer cell lines HMO2 (stomach adenocarcinoma), HEP G2 (hepatocellular carcinoma) and MCF 7 (breast adenocarcinoma) according to the NCI guidelines15). In this test 1 showed a significant
Feeding Experiments
The increased production of cetoniacytone A (1) after (Table 1) .
Finally, feeding of sodium [1-13C] acetate led to the labelling of the carbonyl atom of the acetyl group only.
This corresponds with the proposed pathway, in which the introduction of the acetyl side chain takes place during the late biosynthesis.
Discussion
The cetoniacytones A (1) and B (2) are novel aminocarba sugars produced by an endosymbiontic Actinomyces. 1 resembles to epoxyquinomicin C (4) and D (5) and inhibits the growth of two tumor cell lines. In contrast 4 and 5 show no cytotoxic activity, but display some other interesting biological properties5,6).
The biosynthesis of 1 was established to proceed via the pentose phosphate pathway with sedoheptulose-7-phosphate as the key intermediate. These findings correspond with results from biosynthetic studies on valienamine16) and the gabosines17). We assume that sedoheptulose-7-phosphate (S-7-P) cyclises by an aldol reaction between C-2 and C-7 to yield 2-epi-5-epi-valiolone 
Feeding Experiments
Feeding experiments were carried out in 300ml Erlenmeyer flasks under conditions as described before.
Labelled precursors were dissolved in sterile water and adjusted to pH 7. The labelled precursors were added in five equal aliquots following the pulse feeding method 48, 54, 60, 66 and 72 hours after incubation. The cultures were harvested after 96 hours and worked up as described before. X-Ray Crystallography of Cetoniacytone A (1) mm3 was obtained from a saturated solution in methanol and mounted inside a nylon cryo-loop (Hampton Research) using perfluorated polyether oil19). Crystal data: C9H11NO5, M=213.19g/mol, monoclinic, space group P21, a= were made using a four-circle diffractometer equipped with a Stoe fine-focus, sealed tube X-Ray generator (graphite detector, Huber goniometer and low-temperature device.
The diffractometer was controlled using the SMART carried out using the SAINT program21 Dicyclohexylcarbodiimide (12.8mg; 0.062mmol), 4-dimethylaminopyridine (0.6mg; 0.005mmol) and (R)-2-phenylbutyric acid (10.2mg; 0.062mmol) were added at room temperature to a solution of 1 (6.0mg; 0.028mmol) in 2ml absolute CH2Cl2. The mixture was stirred for 2 hours and the reaction was finished by adding 0.5ml of water. The solvent was evaporated in vacuo and the residue was purified by chromatography on Sephadex LH-20 (CH2Cl2) to yield 8.1mg (57%) of 1a. 1b was obtained by using (S)-2-phenylbutyric acid (10.2mg; 0.062mmol) instead of (R)-2-phenylbutyric acid under the same conditions. The analogous purification yielded 6.9mg (49%) of 1b. For partial 1H NMR assignments of 1a and 1b see Fig. 4 . ESI-MS for 1a and 1b: m/z(%) 528 (100)
[M+Na]+
